Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin R Bailey

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|December 8, 2022
Immunogenicity and Reactogenicity Following 2- and 3-Dose SARS-CoV-2 Vaccination in Persons With HIVMayan S Teles, Stephanie Lushniak, Teresa Po-Yu Chiang, et al.
Immunity|January 3, 2024
Neutralizing antibodies evolve to exploit vulnerable sites in the HCV envelope glycoprotein E2 and mediate spontaneous clearance of infectionNicole Frumento, Ariadne Sinnis-Bourozikas, Harry T Paul, et al.
Cell Reports|May 25, 2022
Sites of vulnerability in HCV E1E2 identified by comprehensive functional screeningJennifer M Pfaff-Kilgore, Edgar Davidson, Kathryn Kadash-Edmondson, et al.
JCI Insight|September 21, 2018
Long-term remission despite clonal expansion of replication-competent HIV-1 isolatesRebecca T Veenhuis, Abena K Kwaa, Caroline C Garliss, et al.
Frontiers in Immunology|April 10, 2023
Convergent antibody responses are associated with broad neutralization of hepatitis C virusNicole E Skinner, Clinton O Ogega, Nicole Frumento, et al.
Nature Communications|September 16, 2022
Serum neutralization activity declines but memory B cells persist after cure of chronic hepatitis CAkira Nishio, Sharika Hasan, Heiyoung Park, et al.
Retrovirology|December 7, 2011
Prolonged control of replication-competent dual- tropic human immunodeficiency virus-1 following cessation of highly active antiretroviral therapyMaria Salgado, S Alireza Rabi, Karen A O'Connell, et al.
Nature Communications|June 8, 2022
Computational identification of HCV neutralizing antibodies with a common HCDR3 disulfide bond motif in the antibody repertoires of infected individualsNina G Bozhanova, Andrew I Flyak, Benjamin P Brown, et al.
Ebiomedicine|February 5, 2017
Factors Associated With the Control of Viral Replication and Virologic Breakthrough in a Recently Infected HIV-1 ControllerVictoria E Walker-Sperling, Christopher W Pohlmeyer, Rebecca T Veenhuis, et al.
Frontiers in Immunology|May 14, 2023
Corrigendum: Convergent antibody responses are associated with broad neutralization of hepatitis C virusNicole E Skinner, Clinton O Ogega, Nicole Frumento, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
Journal of Acquired Immune Deficiency Syndromes (1999)|December 8, 2022
Immunogenicity and Reactogenicity Following 2- and 3-Dose SARS-CoV-2 Vaccination in Persons With HIVMayan S Teles, Stephanie Lushniak, Teresa Po-Yu Chiang, et al.
Immunity|January 3, 2024
Neutralizing antibodies evolve to exploit vulnerable sites in the HCV envelope glycoprotein E2 and mediate spontaneous clearance of infectionNicole Frumento, Ariadne Sinnis-Bourozikas, Harry T Paul, et al.
Cell Reports|May 25, 2022
Sites of vulnerability in HCV E1E2 identified by comprehensive functional screeningJennifer M Pfaff-Kilgore, Edgar Davidson, Kathryn Kadash-Edmondson, et al.
JCI Insight|September 21, 2018
Long-term remission despite clonal expansion of replication-competent HIV-1 isolatesRebecca T Veenhuis, Abena K Kwaa, Caroline C Garliss, et al.
Frontiers in Immunology|April 10, 2023
Convergent antibody responses are associated with broad neutralization of hepatitis C virusNicole E Skinner, Clinton O Ogega, Nicole Frumento, et al.
Nature Communications|September 16, 2022
Serum neutralization activity declines but memory B cells persist after cure of chronic hepatitis CAkira Nishio, Sharika Hasan, Heiyoung Park, et al.
Retrovirology|December 7, 2011
Prolonged control of replication-competent dual- tropic human immunodeficiency virus-1 following cessation of highly active antiretroviral therapyMaria Salgado, S Alireza Rabi, Karen A O'Connell, et al.
Nature Communications|June 8, 2022
Computational identification of HCV neutralizing antibodies with a common HCDR3 disulfide bond motif in the antibody repertoires of infected individualsNina G Bozhanova, Andrew I Flyak, Benjamin P Brown, et al.
Ebiomedicine|February 5, 2017
Factors Associated With the Control of Viral Replication and Virologic Breakthrough in a Recently Infected HIV-1 ControllerVictoria E Walker-Sperling, Christopher W Pohlmeyer, Rebecca T Veenhuis, et al.
Frontiers in Immunology|May 14, 2023
Corrigendum: Convergent antibody responses are associated with broad neutralization of hepatitis C virusNicole E Skinner, Clinton O Ogega, Nicole Frumento, et al.
Pageof 9